Bioanalysis

Since 1990, Eurofins AvTech Laboratories has been a leading provider of fully GLP/GMP compliant contract analysis of therapeutic compounds in a wide variety of biological matrices. In fact, our scientists have developed, validated, or implemented more than 300 bioanalytical methods for analysis of therapeutic compounds in nearly 50 different matrix types.

Bioanalytical Capabilities


Bioanalytical Methods
Eurofins AvTech scientists have developed, validated, or implemented more than 300 bioanalytical methods for analysis of therapeutic compounds in nearly 50 different biological matrix types. A vast majority of these methods are for the analysis of proprietary compounds. Methods for the compounds listed below, however, may be applied to address the bioanalytical needs of any of our clients.
Cisapride
CPT-11
L-Dopa
Tryamin 		Ranitidine
SN-38
Valproic Acid
R,S,-Warfarin
Additional bioanalytical methods are available.

  • Rapid Turn Around Support for non-GLP Discovery Projects
  • GLP Pre-Clinical or Clinical Sample Analysis
  • Metabolite ID
  • Dose Formulation Analysis
  • Analysis Down to Picogram Levels

Specific Expertise

  • Method Development & Validation
  • DMPK Expertise Including Study Design, Sample & PK Analysis, and Report Preparation
  • Extensive Sample Extraction Experience
  • Broad Range of Separation Techniques
  • Experience with Nearly 50 Types of Matrix
  • Drug Residue Analysis by LC-MS-MS

Equipment & Systems

  • Numerous LC-MS-MS Platforms
  • UPLC® (Waters Acquity) and Traditional HPLC Systems
  • GC-MS
  • Watson® LIMS for Data Processing and Result Reporting

Download this information about Bioanalysis at Eurofins AvTech as a PDF.